Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinoic acid decreases targeting of p27 for degradation via an N-myc-dependent decrease in p27 phosphorylation and

M Nakamura1, T Matsuo, J Stauffer

  • 1Cell and Molecular Biology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Cell Death and Differentiation
|April 18, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated oxidative stress in pied flycatcher nestlings of eumelanic foster fathers under low rearing temperatures.

The Journal of experimental biology·2019
Same author

Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma.

Oncogene·2016
Same author

Interspecific variation in redox status regulation and immune defence in five bat species: the role of ectoparasites.

Oecologia·2014
Same author

Resistance to oxidative damage but not immunosuppression by organic tin compounds in natural populations of Daubenton's bats (Myotis daubentonii).

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP·2013
Same author

Episome generated C-myc antisense RNA inhibits growth and tumorigenicity of a human neuroendocrine tumor-cell line.

International journal of oncology·2011
Same author

CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression.

Cell death and differentiation·2011

Retinoic acid (RA) combats neuroblastoma (NB) by reducing N-myc and increasing p27 levels, halting cancer cell growth. RA achieves this through N-myc-dependent and -independent pathways, inhibiting p27 degradation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Neuroblastoma (NB) prognosis is linked to N-myc amplification and overexpression.
  • Retinoic acid (RA) shows therapeutic potential by decreasing N-myc and inducing cell cycle arrest in NB.

Purpose of the Study:

  • To elucidate the mechanisms of RA-induced cell cycle regulation in NB.
  • To understand how N-myc influences NB cell cycle progression.

Main Methods:

  • Investigated the role of N-myc in regulating cyclin E-dependent kinase activity and p27 levels.
  • Assessed the impact of N-myc on p27 targeting to the proteasome and proteasome activity.
  • Examined RA's effects on N-myc levels, p27 degradation, phosphorylation, ubiquitination, and Skp2 levels.

Related Experiment Videos

Main Results:

  • N-myc overexpression increases cyclin E-dependent kinase activity, decreases p27, and enhances DNA synthesis.
  • N-myc promotes p27 degradation via phosphorylation and ubiquitination, increasing proteasome activity.
  • RA treatment reduces N-myc, increases p27, and decreases p27 degradation through both N-myc-dependent and -independent pathways, including reduced p27 phosphorylation and lower Skp2 levels.

Conclusions:

  • RA effectively arrests NB cell growth by stabilizing p27.
  • Both N-myc-dependent and -independent mechanisms contribute to RA's anti-neuroblastoma effects.
  • Targeting p27 stabilization presents a promising therapeutic strategy for neuroblastoma.